[Ablative hormone therapy and chemotherapy of metastatic breast cancer].
Case report of a 45-year-old woman with breast cancer who underwent mastectomy with axillary lymphonodectomy and radiation therapy. Two years after primary therapy liver metastases have been proved by sonography, liver scintigraphy and computerized tomography scanning. A nearly complete remission was achieved by ablative hormone therapy and CMF-chemotherapy.
Kasch
R
R
Klinik für Gynäkologie und Geburtshilfe, Bereichs Medizin der Wilhelm-Pieck-Universität Rostock.
Gerber
B
B
Blaschke
U
U
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery; D008197:Lymph Node Excision; D008408:Mastectomy; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000601:surgery*; D010052:Ovariectomy
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Ablative Hormontherapie und Chemotherapie beim metastasierenden Mammakarzinom.